Concepedia

David Tattersall

DT

3

Publications

262

Citations

3

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

David Tattersall is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

2004–2017

3

Publications

3

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

Chris S Busse, Jesse Brodkin, David Tattersall et al. · Neuropsychopharmacology · 2004 · 157 citations · Full text

, , +11

An Alternative Cuprizone-Induced Demyelination and Remyelination Mouse Model

Zhen Wei, Ailian Liu, Jiaqi Lu et al. · ASN NEURO · 2017 · 64 citations · Full text

, , +21

Imidazo[1,2-a]pyrimidines as functionally selective GABAA ligands

Wesley Blackaby, John Atack, Frances A. Bromidge et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 41 citations · Full text

, , +3

Rows per page

1–3 of 3